Rare genetic diseases are expected to fuel the growth of the stem cell therapy market. Rare disorders such as thalassemia, phenylketonuria, cystic fibrosis, and others affect millions of individuals each year. According to World Health Organization (WHO), chronic diseases cause 41 million mortalities every year, equivalent to 71% of all mortalities globally. Traditional therapies and pharmaceuticals have proven ineffective in addressing various ailments, thereby, people are increasingly turning to advanced stem cell therapies, which will boost industry numbers.
Colin Horan Estate Agent
Bengalbet88live
Flamingo Cleaning2026
Ae888
99oka Com
Nexus Expert Research
Tax Savers
Quote My Wall
Ashley Lush
Hi77 Work